Breaking News Instant updates and real-time market news.

RBS

RBS

$4.91

0.09 (1.87%)

06:02
11/30/16
11/30
06:02
11/30/16
06:02

RBS to take actions to boost capital levels after failing BOE stress test

The Royal Bank of Scotland Group notes the announcement made by the Bank of England regarding the results of its 2016 stress test. The test applied a hypothetical adverse scenario to the Group's balance sheet as at 31 December 2015 and compared the theoretical Common Equity Tier 1 ratio and Tier 1 leverage ratio positions of RBS before and after the impact of strategic management actions, including CRD IV distribution restrictions and conversion of Additional Tier 1 securities, RBS's low point CET1 ratio under the hypothetical adverse scenario would have been 5.5% which is below RBS's updated 6.6% Individual Capital Guidance and below the post-stress CET1 Systemic Reference Point of 7.1%. After the impact of management actions and restriction of the CRD IV distribution, the ratio would have been 5.9%; and subsequently 6.7% post the conversion of AT1 securities. This takes the result above the ICG hurdle rate of 6.6% but it remains below the SRP of 7.1%. RBS's Tier 1 leverage ratio under the hypothetical adverse scenario would have been 2.7% which is below the hurdle rate of 3.0% and below the post-stress leverage ratio SRP of 3.2%. After the impact of management actions, the ratio would have been 2.9%, which remains below both the hurdle rate and the Tier 1 leverage ratio SRP. The bank has taken a number of actions since 31 December 2015 to improve its capital position stress resilience, including the on-going run-down of Capital Resolution reduced by 21% to GBP38.6 billion in the first nine months of 2016, the continued reduction in higher risk credit portfolios, the settlement of various litigation cases and regulatory investigations and the issuance of an additional GBP 2 billion equivalent in AT1 securities. A number of these actions impacted our CET1 ratio which was 15.0% as at Q3 2016, compared to 15.5% as at FY 2015. This is above RBS's CET1 ratio target of 13.0%. RBS has agreed a revised capital plan with the PRA to improve its stress resilience in light of the various challenges and uncertainties facing both the bank and the wider economy highlighted by the concurrent stress testing process. RBS intends to execute an array of capital management actions to supplement the organic capital generation from its core franchises and further improve its stress resilience, including: further decreasing the cost base of the bank; further reductions in RWAs across the bank; further run-down and sale of other non-core loan portfolios in relation to our personal and commercial franchises; reduction in certain non-core commercial portfolios in Commercial Banking; and the proactive management of undrawn facilities in 2017. RBS expects its revised capital plan to address the shortfall identified in today's stress test results. However, additional management actions may be required until RBS's balance sheet is sufficiently resilient to stressed scenarios.

RBS RBS
$4.91

0.09 (1.87%)

09/05/16
DBAB
09/05/16
DOWNGRADE
DBAB
Sell
RBS downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst David Lock downgraded Royal Bank of Scotland Group to Sell saying the "lower-for-longer" interest rate environment following the Brexit vote is a negative for the sector.
09/05/16
DBAB
09/05/16
DOWNGRADE
DBAB
Hold
Lloyds Banking downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst David Lock downgraded Lloyds Banking Group to Hold saying the "lower-for-longer" interest rate environment following the Brexit vote is a negative for the sector. Lock also downgraded RBS (RBS) this morning to Sell.
11/18/16
EXAN
11/18/16
DOWNGRADE
EXAN
Underperform
RBS downgraded to Underperform from Neutral at Exane BNP Paribas
Exane BNP Paribas analyst Tom Rayner downgraded Royal Bank of Scotland to Underperform with a price target of GBP 195.
11/29/16
FBCO
11/29/16
INITIATION
FBCO
Underperform
RBS initiated with an Underperform at Credit Suisse
Price target 180p.

TODAY'S FREE FLY STORIES

BABA

Alibaba

$156.64

-2.12 (-1.34%)

05:36
09/19/18
09/19
05:36
09/19/18
05:36
Hot Stocks
Alibaba Cloud to work with Kenyan Ministry to protect wildlife »

Alibaba Cloud, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

WBC

Wabco

$114.86

-0.6 (-0.52%)

05:33
09/19/18
09/19
05:33
09/19/18
05:33
Hot Stocks
Wabco, Valeo sign MoU to develop sensor technologies »

Wabco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 06

    Nov

GE

General Electric

$12.67

-0.04 (-0.31%)

05:25
09/19/18
09/19
05:25
09/19/18
05:25
Hot Stocks
GE Transportation locomotives approved for operation by Indian Railways »

GE Transportation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

DCPH

Deciphera

$36.16

1.48 (4.27%)

, NVS

Novartis

$85.03

-0.1 (-0.12%)

05:21
09/19/18
09/19
05:21
09/19/18
05:21
Recommendations
Deciphera, Novartis, Blueprint Medicines analyst commentary  »

Piper recommends…

DCPH

Deciphera

$36.16

1.48 (4.27%)

NVS

Novartis

$85.03

-0.1 (-0.12%)

BPMC

Blueprint Medicines

$70.95

2.33 (3.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

  • 27

    Nov

CLCT

Collectors Universe

$15.04

-0.26 (-1.70%)

05:14
09/19/18
09/19
05:14
09/19/18
05:14
Hot Stocks
Collectors Universe announces termination of COO David Hall »

Collectors Universe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MB

Mindbody

$41.05

1 (2.50%)

05:12
09/19/18
09/19
05:12
09/19/18
05:12
Recommendations
Mindbody analyst commentary  »

Mindbody comments on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$92.60

-2.77 (-2.90%)

05:07
09/19/18
09/19
05:07
09/19/18
05:07
Recommendations
AbbVie analyst commentary  »

Piper more worried about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$102.16

-1.3 (-1.26%)

05:01
09/19/18
09/19
05:01
09/19/18
05:01
Downgrade
LyondellBasell rating change  »

LyondellBasell downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSEZY

SSE

$0.00

(0.00%)

04:57
09/19/18
09/19
04:57
09/19/18
04:57
Upgrade
SSE rating change  »

SSE upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HHC

Howard Hughes

$124.65

-0.88 (-0.70%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Howard Hughes management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

BAESY

BAE Systems

$0.00

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
BAE Systems management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Housing Starts to be reported at 08:30 »

August Housing Starts…

NEE

NextEra Energy

$173.44

-0.41 (-0.24%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
NextEra Energy management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 11

    Nov

RWT

Redwood Trust

$16.42

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Redwood Trust management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

AMSF

Amerisafe

$63.80

-0.35 (-0.55%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Amerisafe management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

NHI

National Health Investors

$76.47

-1.07 (-1.38%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
National Health Investors management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

AKTS

Akoustis

$8.08

0.04 (0.50%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Akoustis management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

NICE

Nice Systems

$115.64

-0.61 (-0.52%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Nice Systems management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GCI

Gannett

$9.92

0.135 (1.38%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Gannett management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

ATTO

Atento

$7.60

-0.1 (-1.30%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Atento management to meet with Barrington »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
RBC Capital hardware analyst to hold a group luncheon »

Hardware & Semis…

ALLK

Allakos

$44.88

0.95 (2.16%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

WCN

Waste Connections

$80.19

0.745 (0.94%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Waste Connections participates in a conference call with UBS »

Analyst Windham holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Breaking General news story  »

Week of 9/14 EIA…

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Breaking General news story  »

Week of 9/14 MBA Mortgage…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.